ES2165947T3 - Metodo para medir la cantidad de un constituyente contenido en una lipoproteina especifica. - Google Patents

Metodo para medir la cantidad de un constituyente contenido en una lipoproteina especifica.

Info

Publication number
ES2165947T3
ES2165947T3 ES96111431T ES96111431T ES2165947T3 ES 2165947 T3 ES2165947 T3 ES 2165947T3 ES 96111431 T ES96111431 T ES 96111431T ES 96111431 T ES96111431 T ES 96111431T ES 2165947 T3 ES2165947 T3 ES 2165947T3
Authority
ES
Spain
Prior art keywords
amount
measuring
lipoprotein
contained
specific lipoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96111431T
Other languages
English (en)
Inventor
Yutaka Miki
Toshiro Hanada
Kiyoko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd filed Critical Wako Pure Chemical Industries Ltd
Application granted granted Critical
Publication of ES2165947T3 publication Critical patent/ES2165947T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/59—Transmissivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/805—Test papers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE SUMINISTRA UN METODO PARA MEDIR LA CANTIDAD DE CONSTITUYENTE OBJETIVO PARA LA MEDIDA CONTENIDA EN LA LIPOPROTEINA ESPECIFICA EN UNA MUESTRA VIVA TAL COMO SUERO Y PLASMA, ESPECIFICAMENTE PARA MEDIR LA CANTIDAD DE COLESTEROL CONTENIDO EN UNA LIPOPROTEINA DE ALTA DENSIDAD, QUE PUEDE APLICARSE A ENSAYOS CLINICOS. LA INVENCION TAMBIEN SUMINISTRA UN EQUIPO PARA MEDIR LA CANTIDAD DE CONSTITUYENTE OBJETIVO CONTENIDA EN LA LIPOPROTEINA ESPECIFICA, QUE COMPRENDE I) UNA COMPOSICION DE REACTIVO QUE CONTIENE UN ANTICUERPO REACTIVO CON LAS LIPOPROTEINAS DIFERENTES DE LA LIPOPROTEINA ESPECIFICA, Y UN AGENTE NEUTRALIZADOR; Y II) UNA COMPOSICION DE REAGENTE QUE CONTIENE UN REAGENTE PARA MEDIR LA CANTIDAD DE CONSTITUYENTE OBJETIVO CONTENIDO EN UNA LIPOPROTEINA Y UN AGENTE NEUTRALIZADOR.
ES96111431T 1995-07-21 1996-07-16 Metodo para medir la cantidad de un constituyente contenido en una lipoproteina especifica. Expired - Lifetime ES2165947T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20766395 1995-07-21

Publications (1)

Publication Number Publication Date
ES2165947T3 true ES2165947T3 (es) 2002-04-01

Family

ID=16543503

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96111431T Expired - Lifetime ES2165947T3 (es) 1995-07-21 1996-07-16 Metodo para medir la cantidad de un constituyente contenido en una lipoproteina especifica.

Country Status (4)

Country Link
US (2) US6162607A (es)
EP (1) EP0754948B1 (es)
DE (1) DE69615956T2 (es)
ES (1) ES2165947T3 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010108370A (ko) * 1999-03-24 2001-12-07 구니요시 이에지 콜레스테롤의 정량법
WO2000073797A2 (en) * 1999-05-28 2000-12-07 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Homogeneous tests for sequentially determining lipoprotein fractions
DE10204606C1 (de) * 2002-01-18 2003-10-16 Cholestech Corp Vorrichtung und Verfahren für Lipoproteine hoher Dichte
DE60207196T2 (de) * 2002-04-09 2006-07-20 Cholestech Corp., Hayward Verfahren und Vorrichtung zur Quantifizierung von Lipoprotein-Cholesterol hoher Dichte
EP1555326B1 (en) * 2002-10-16 2009-11-25 Kyowa Medex Co., Ltd. Method and reagent for measuring cholesterol in high density lipoproteins
US20050124019A1 (en) * 2003-11-04 2005-06-09 Jones Ronald M. Reagent-containing membranes and laminates and methods of their preparation
US7772007B2 (en) * 2004-04-02 2010-08-10 Cholestech Corporation Assay device for direct measurement of LDL cholesterol
TWI372783B (en) * 2005-04-27 2012-09-21 Kyowa Medex Co Ltd A process for measuring the cholesterol in high density lipoprotein
WO2007007392A1 (ja) 2005-07-11 2007-01-18 Wako Pure Chemical Industries, Ltd. 新規ポリマー及びこれを用いたコレステロール測定法
EP2126587B1 (en) * 2007-01-09 2010-09-29 Cholestech Corporation Device and method for measuring ldl-associated cholesterol
NZ589315A (en) * 2008-04-16 2012-11-30 Portola Pharm Inc 2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors
WO2010148130A1 (en) * 2009-06-17 2010-12-23 Maine Standards Company, Llc Method for measuring lipoprotein-specific apolipoproteins
EP2490028B1 (en) * 2009-10-14 2016-11-30 National University Corporation Hamamatsu University School of Medicine Method and marker for determination of degree of risk of onset of high-functioning autism
CN102507957A (zh) * 2011-11-01 2012-06-20 北京利德曼生化股份有限公司 一种用免疫透射比浊法测定载脂蛋白a2的方法及试剂盒
KR102381248B1 (ko) 2011-11-11 2022-04-01 엑시스-시일드 에이에스 혈액 샘플 분석 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701800A (nl) * 1977-02-18 1978-08-22 Akzo Nv Testkit en methode voor de bepaling van lp-x.
DE2829531A1 (de) * 1978-07-05 1980-01-24 Heuck Claus Christian Dr Rer N Verfahren zur quantitativen bestimmung eines serumproteins in getruebten serum- und plasma-proben
DE3215310A1 (de) * 1982-04-23 1983-10-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
DE3636851A1 (de) * 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
US5403745A (en) * 1990-04-27 1995-04-04 Genzyme Corporation Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
AU9088891A (en) * 1990-11-29 1992-06-25 John E. Carbaugh Diagnostic and therapeutic compositions and methods for lipoprotein(a)
DE69125468T2 (de) * 1990-12-28 1997-07-17 Fujitsu Ltd Bargeldbearbeitungssystem
JP3107474B2 (ja) 1993-02-17 2000-11-06 国際試薬株式会社 リポ蛋白分画中の成分の定量方法
JP2653755B2 (ja) 1994-03-08 1997-09-17 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの定量法
JP2598233B2 (ja) 1994-08-31 1997-04-09 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの定量法
JP2799835B2 (ja) 1995-01-31 1998-09-21 第一化学薬品株式会社 コレステロールの定量方法
US5814472A (en) 1997-05-13 1998-09-29 Wako Pure Chemical Industries, Ltd. Measurement of LDL-cholesterol
US5925534A (en) 1998-06-08 1999-07-20 Wako Pure Chemical Industries, Ltd. Method for measuring LDL-cholesterol

Also Published As

Publication number Publication date
US6162607A (en) 2000-12-19
DE69615956D1 (de) 2001-11-22
US7223546B2 (en) 2007-05-29
EP0754948B1 (en) 2001-10-17
DE69615956T2 (de) 2002-06-20
EP0754948A1 (en) 1997-01-22
US20030180809A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
ES2165947T3 (es) Metodo para medir la cantidad de un constituyente contenido en una lipoproteina especifica.
Dai et al. Evidence for oxidised low density lipoprotein in synovial fluid from rheumatoid arthritis patients
ES2118062T3 (es) Composiciones reactivas, metodos y reactivos para la valoracion cuantitativa de magnesio o de calcio y magnesio.
ES2166429T3 (es) Dispositivo de analisis que comprende un colorante copulante estable, para la determinacion de analitos.
AU6177898A (en) Reagent dispenser and related test kit for biological specimens
BR9802494A (pt) Método para determinar a espessura de uma amostra ótica.
MX9604514A (es) Metodo para determinar cuantitativamente colesterol.
IL142647A0 (en) A method and kit for measuring proteasome activity
FI980874A0 (fi) Menetelmä ja laite pienten nestemäärien kemiallisen analyysin suorittamiseksi
WO2006007841A3 (en) Heat-induced antigen retrieval methods and compositions therefor
ATE497544T1 (de) Verfahren zur quantifizierung von hochdichtem lipoproteincholesterol
BR0211011A (pt) Composição, método para fornecimento de estabilidade fìsica, método para tratamento de fibras queratìnicas e kit de múltiplos compartimentos
CY1105245T1 (el) Μεθοδος προεπεξepγασιας δειγματος για επιμετρηση χοληστepολης και μεθοδος επιμετρησης χοληστepολης σε συγκεκριμενες λιποπρωτεϊνες χρησιμοποιωντας αυτη τη μεθοδο
WO2006036738A3 (en) Photometric analysis
ES2128372T3 (es) Un metodo quimioluminiscente para la cuantificacion de adn humano.
ES2142936T3 (es) Metodo para detectar marihuana en una muestra de cabello.
BR9800254A (pt) Reagente de coloração para a determinação de células sanguíneas
ATE258310T1 (de) Testverfahren für collagenpeptid
ES2095787T3 (es) Conjunto, procedimiento, dispositivo y composicion de tinte de fibras queratinicas.
ATE294240T1 (de) Verfahren und kit, um biologische substanzen in plasmamembran und/oder zytosol einzuführen
ES2179438T3 (es) Procedimiento y dispositivo para la distribucion fraccionada de una muestra de sangre.
ES2119001T3 (es) Determinacion de un analito en una muestra liquida.
PT1003458E (pt) Teste de funcao hepatica
BR0014626A (pt) Análise de leptina
WO2002044739A3 (en) Method for automatically storing and reprocessing patient specimens in an automatic clinical analyzer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 754948

Country of ref document: ES